Company: IPSC
Filing Date: 2025-11-21
Form Type: PRE 14A
Source: 0001104659-25-114992
Chunk: 1

Company: Century Therapeutics, Inc.
Filing Date: 2025-11-21
Form: PRE 14A
Chunk 1
---
 Stockholders (the “Special Meeting”), of Century Therapeutics, Inc. (“Century”, the “Company”, “we”, or “us”), which will be held virtually at 9:00 a.m., Eastern Time, on January 22, 2026 for the following purposes: 1. to approve an amendment to our Second Amended and Restated Certificate of Incorporation, as amended (the “Charter”), to effect a reverse stock split of our outstanding shares of common stock, par value $0.0001 per share (“Common Stock”) by a ratio of any whole number between 1-for-5 and 1-for-30, the implementation and timing of which shall be subject to the discretion of our Board of Directors (the “Board”); and 2. to approve adjournment of the Special Meeting to the extent there are insufficient votes at the Special Meeting to approve the preceding proposal or to establish a quorum. The Special Meeting can be accessed via the Internet at https://edge.media-server.com/mmc/p/xqpg9wru using the password century2026. Details regarding the business to be conducted at the Special Meeting are more fully described in the accompanying Notice of 2026 Special Meeting of Stockholders (the “Notice”) and 2026 Special Meeting Proxy Statement (the “Proxy Statement”). You are entitled to vote at our Special Meeting and any adjournments thereof only if you were a stockholder as of November 25, 2025. Your vote is important . Whether or not you plan to virtually attend the Special Meeting, we encourage you to vote as soon as possible to ensure that your shares are represented. Information about voting methods is set forth in the accompanying Notice and Proxy Statement. If you have any questions with respect to voting, please call our Senior Vice President, Finance and Operations, Douglas Carr, at (267) 817-5790. Sincerely,

| ​ | ​                                                                                       
 Brent Pfeiffenberger, Pharm.D.President, Chief Executive Officer &Chairman of the Board | ​ | ​ | ​ | ​ |

THIS PROXY STATEMENT AND ENCLOSED PROXY CARD ARE
FIRST BEING MADE AVAILABLE ON OR ABOUT DECEMBER 2, 2025.

NOTICE OF 2026 SPECIAL MEETING OF STOCKHOLDERS To be Held on January 22, 2026 Dear Stockholders: You are invited to attend Century’s Special Meeting. At the Special Meeting, stockholders will vote: 1. to approve an